Atualizações Científicas
18/01/2019 | Fibrose Pulmonar Idiopática
| Diálogo TV
| Webmeeting
| Pneumologia
Webmeeting: Discussão multidisciplinar de pirfenidona em pacientes com refluxo gastroesofágico e transtornos de humor
17/12/2018 | Diálogo TV
| Fibrose Cística
| Pediatria
| Pneumologia
Dr. Dráuzio Varella fala sobre Fibrose Cística
14/12/2018 | Oncologia
| Melanoma
| Tipo de conteúdo
Roche na Pele
14/12/2018 | Carreira e Tecnologia
| Carreira Médica
| Artigos
Endomarketing: como aplicá-lo no consultório ou clínica?
10/12/2018 | Neurologia
| Vídeo
| Diálogo TV
| Esclerose Múltipla
Long-Term Reduction of Relapse Rate and Confirmed Disability Progression After 5 Years of Ocrelizumab Treatment in Patients with Relapsing Multiple Sclerosis
10/12/2018 | Neurologia
| Vídeo
| Diálogo TV
| Esclerose Múltipla
Sustained Reduction in Confirmed Disability Progression in Patients With Primary Progressive Multiple Sclerosis Treated with Ocrelizumab in the Open-Label Extension Period of the Phase III ORATORIO Trial
10/12/2018 | Neurologia
| Vídeo
| Diálogo TV
| Esclerose Múltipla
Ocrelizumab Treatment Effect on Upper Limb Function in PPMS Patients with Disability: Subgroup Results of the ORATORIO Study to Inform the ORATORIO-HAND Study Design
07/12/2018 | Carreira e Tecnologia
| Carreira Médica
| Artigos
Publicidade na Medicina
07/12/2018 | Neurologia
| Vídeo
| Diálogo TV
| Esclerose Múltipla
Integration of Ocrelizumab Safety Data From the German Study CONFIDENCE Into the Global Post-Marketing Safety Studies MANUSCRIPT and VERISMO
07/12/2018 | Neurologia
| Vídeo
| Diálogo TV
| Esclerose Múltipla
An Update on Pregnancy Outcomes Following Ocrelizumab Treatment in Patients With Multiple Sclerosis and Other Autoimmune Diseases
07/12/2018 | Neurologia
| Vídeo
| Diálogo TV
| Esclerose Múltipla
Patient-Reported SymptoMScreen Baseline Scores in Patients With Relapsing-Remitting Multiple Sclerosis Enrolled in Phase IIIb Studies of Ocrelizumab (ENSEMBLE and CASTING)
06/12/2018 | Neurologia
| Vídeo
| Diálogo TV
| Esclerose Múltipla
Relapse-Associated Worsening and Progression Independent of Relapse Activity in Patients With Relapsing Multiple Sclerosis in the Phase III OPERA I and OPERA II Studies
06/12/2018 | Neurologia
| Vídeo
| Diálogo TV
| Esclerose Múltipla
Safety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients with Relapsing and Primary Progressive Multiple Sclerosis
06/12/2018 | Neurologia
| Vídeo
| Diálogo TV
| Esclerose Múltipla
Subgroup Analysis to Evaluate the Efficacy of Ocrelizumab Versus Interferon - 1ª in African-Descended Patients With Relapsing Multiple Sclerosis in the OPERA I and OPERA II Studies
06/12/2018 | Neurologia
| Vídeo
| Diálogo TV
| Esclerose Múltipla
Long-Term Reduction in Brain MRI Disease Activity and Atrophy After 5 Years of Ocrelizumab Treatment in Patients With Relapsing Multiple Sclerosis
06/12/2018 | Neurologia
| Vídeo
| Diálogo TV
| Esclerose Múltipla
Year One Interim Analysis Results of the Phase IIIb CHORDS Study Evaluating Ocrelizumab Effectiveness and Safety in Patients with Relapsing-Remitting Multiple Sclerosis Who Had Suboptimal Response with Prior Disease-Modifying Treatments
06/12/2018 | Neurologia
| Vídeo
| Diálogo TV
| Esclerose Múltipla
FLOODLIGHT: Smartphone-Based Self-Monitoring Is Accepted by Patients and Provides Meaningful, Continuous Digital Outcomes Augmenting Conventional In-Clinic Multiple Sclerosis Measures
Diálogo TV
Discussão sobre falha de tratamento, prognóstico da doença...
06/09/2018
Aula do Dr. Cesar Y. Fukuda - Avaliação prognóstica em Fibrose Pulmonar Idiopática
06/09/2018
Caso clínico: Fibrose pulmonar familiar
06/09/2018
Caso clínico: Doença pulmonar fibrosante piorada após uso de metotrexate
06/09/2018
Parceiros
Utilizamos cookies para melhoriar a sua experiência. Ao continuar navegando, você concorda com o uso de cookies.
close